Gene expression signatures associated with sensitivity to azacitidine in myelodysplastic syndromes

Allogeneic stem cell transplantation is currently the only curative treatment option for myelodysplastic syndromes (MDS). Pre-transplant debulking treatment have been employed for advanced MDS and we previously reported that marrow response (blast ≤ 5%) following the bridging therapy with hypomethyl...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kyuryung, Park, Silvia, Choi, Hayoung, Kim, Hye Joung, Kwon, Yong-Rim, Ryu, Daeun, Kim, Myungshin, Kim, Tae-Min, Kim, Yoo-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658235/
https://www.ncbi.nlm.nih.gov/pubmed/33177628
http://dx.doi.org/10.1038/s41598-020-76510-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658235/
https://www.ncbi.nlm.nih.gov/pubmed/33177628
http://dx.doi.org/10.1038/s41598-020-76510-7

Ejemplares similares